Who would I not give IIb/IIIa inhibitors to during percutaneous coronary intervention?

In the original NICE guideline, published in September 2000, Gp IIb/IIIa inhibitors were recommended for all patients undergoing PCI, whether acute or elective. 4 In the recently published revised guidance, 5 Gp IIb/IIIa inhibitors are recommended in many patient groups, including diabetic patients...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British heart journal 2003-05, Vol.89 (5), p.477-478
1. Verfasser:	McLenachan, J M
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute coronary syndromes Age Age Factors Aged Angioplasty, Balloon, Coronary - adverse effects Angioplasty, Balloon, Coronary - methods Coronary vessels Decision Making Diabetes Drug dosages Fatalities glycoprotein IIb/IIIa inhibitors Heart attacks Heart diseases Humans Mortality Patient Selection percutaneous coronary intervention Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors Risk Assessment Risk Factors Stents Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!